Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison.
about
A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signatureDelineation of radiation therapy target volumes for patients with postoperative glioblastoma: a reviewCan irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era.DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registriesIDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial.Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.Can the prognosis of individual patients with glioblastoma be predicted using an online calculator?Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy.Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.405 nm versus 633 nm for protoporphyrin IX excitation in fluorescence-guided stereotactic biopsy of brain tumors.Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
P2860
Q21560781-9629DA82-3D36-4ED7-BB37-D5F24B8F9B24Q26745588-68FE8DBB-2078-4C4A-A7F7-1AF0769DC556Q31060786-580DB27B-422A-4ABC-B543-F64DE5CA99C1Q33913598-2D71A6EA-6E81-45BB-B211-229233812CD0Q34215037-5470BFB1-5301-4AAF-92E7-D5566371B8EBQ35605776-4E35BF85-D1D7-49D8-B038-7695FD15AE43Q35686908-CD069776-5227-4DA0-A9D6-9B9F457655C2Q36320980-BD1C81C6-307A-4D01-91FE-DDE11078C75DQ36371890-67D0B928-E018-4212-8BB5-7A2BFDD71ABEQ36411906-E78DCF74-5F82-4D66-9C97-81C073ADA5ABQ37021532-A5C52041-FD13-4A78-840D-9D8CC732E8AEQ37187292-EB9B3578-5FA6-4537-AEC3-867AFBA93059Q37734374-A3659DB4-B548-41B4-B862-E3674635616BQ50278124-6C0B077A-B896-4C2C-9922-CBD328F7E6CAQ53201325-2A0173B8-DAA5-4F6B-A757-BF103BF68871
P2860
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Age as an independent prognost ...... l Cancer Data Base comparison.
@ast
Age as an independent prognost ...... l Cancer Data Base comparison.
@en
type
label
Age as an independent prognost ...... l Cancer Data Base comparison.
@ast
Age as an independent prognost ...... l Cancer Data Base comparison.
@en
prefLabel
Age as an independent prognost ...... l Cancer Data Base comparison.
@ast
Age as an independent prognost ...... l Cancer Data Base comparison.
@en
P2093
P2860
P1476
Age as an independent prognost ...... l Cancer Data Base comparison.
@en
P2093
Arnab Chakravarti
Christopher T Coughlin
Diana F Nelson
Jeff M Michalski
John Delrowe
Kimberly Porter
Luis Souhami
Malika L Siker
Meihua Wang
W K Alfred Yung
P2860
P2888
P304
P356
10.1007/S11060-010-0500-6
P50
P577
2011-01-09T00:00:00Z
P6179
1048245051